Schechter Investment Advisors LLC Cuts Stock Position in Avantor, Inc. (NYSE:AVTR)

Schechter Investment Advisors LLC lessened its stake in Avantor, Inc. (NYSE:AVTR) by 2.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 21,244 shares of the company’s stock after selling 608 shares during the quarter. Schechter Investment Advisors LLC’s holdings in Avantor were worth $485,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Credit Suisse AG grew its holdings in shares of Avantor by 43.5% during the second quarter. Credit Suisse AG now owns 1,254,238 shares of the company’s stock worth $25,762,000 after buying an additional 380,114 shares in the last quarter. Northern Trust Corp grew its holdings in shares of Avantor by 9.0% during the third quarter. Northern Trust Corp now owns 4,129,447 shares of the company’s stock worth $87,049,000 after buying an additional 342,553 shares in the last quarter. State Board of Administration of Florida Retirement System grew its holdings in shares of Avantor by 12.7% during the third quarter. State Board of Administration of Florida Retirement System now owns 658,563 shares of the company’s stock worth $13,883,000 after buying an additional 74,078 shares in the last quarter. Aviva PLC grew its holdings in shares of Avantor by 47.5% during the third quarter. Aviva PLC now owns 235,591 shares of the company’s stock worth $4,966,000 after buying an additional 75,898 shares in the last quarter. Finally, Bank of Nova Scotia grew its holdings in shares of Avantor by 18.1% during the third quarter. Bank of Nova Scotia now owns 16,024 shares of the company’s stock worth $338,000 after buying an additional 2,455 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Trading Down 0.1 %

NYSE AVTR opened at $25.55 on Friday. The firm’s 50-day moving average is $24.14 and its two-hundred day moving average is $22.01. Avantor, Inc. has a 12 month low of $16.63 and a 12 month high of $26.16. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.61 and a quick ratio of 1.05. The stock has a market capitalization of $17.33 billion, a P/E ratio of 53.23, a PEG ratio of 1.60 and a beta of 1.37.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.03. The business had revenue of $1.72 billion for the quarter, compared to analysts’ expectations of $1.70 billion. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The business’s quarterly revenue was down 4.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.32 earnings per share. On average, sell-side analysts anticipate that Avantor, Inc. will post 1.01 earnings per share for the current year.

Insider Transactions at Avantor

In other news, EVP James Bramwell sold 6,203 shares of the stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total transaction of $151,911.47. Following the sale, the executive vice president now owns 101,143 shares of the company’s stock, valued at $2,476,992.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.50% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Evercore ISI raised shares of Avantor from an “in-line” rating to an “outperform” rating and upped their target price for the stock from $19.50 to $26.00 in a report on Thursday, January 4th. Robert W. Baird boosted their price target on shares of Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Thursday, February 15th. UBS Group boosted their price target on shares of Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. JPMorgan Chase & Co. boosted their price target on shares of Avantor from $26.00 to $29.00 and gave the company an “overweight” rating in a research report on Thursday, February 15th. Finally, Raymond James boosted their price target on shares of Avantor from $22.50 to $26.00 and gave the company an “outperform” rating in a research report on Friday, January 26th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, Avantor currently has a consensus rating of “Moderate Buy” and an average target price of $26.14.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.